TeraImmune: Funding, Investors & Team (Oct 2026)
Developer of cell therapeutics created for autoimmune diseases and immune-related disorders. The company uses regulatory T (Treg) cells from a donor and makes Treg cells for hemophilia, multiple sclerosis and graft-versus-host disease from stem cell transplantation, enabling the healthcare industry to suppress the unwanted immune reactions without side effects in patients with autoimmune diseases.
TeraImmune has raised $3.0M across 1 funding round on record, the most recent an undisclosed round of $3.0M announced in Dec 2022.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
TeraImmune Company Profile and Key Stats
Latest funding round on record: Dec 2022.
TeraImmune Funding Rounds
TeraImmune Founders and Leadership Team
No contact details are on record for this team yet.
TeraImmune Funding Compared to Other Biotechnology Startups
TeraImmune's latest round of $3.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like TeraImmune in Biotechnology and Gaithersburg
Companies Similar to TeraImmune
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
TeraImmune Funding FAQs
What does TeraImmune do?
Developer of cell therapeutics created for autoimmune diseases and immune-related disorders. The company uses regulatory T (Treg) cells from a donor and makes Treg cells for hemophilia, multiple sclerosis and graft-versus-host disease from stem cell transplantation, enabling the healthcare industry to suppress the unwanted immune reactions without side effects in patients with autoimmune diseases.
How much funding has TeraImmune raised?
TeraImmune has raised $3.0M across 1 round on record. The most recent is an undisclosed round of $3.0M announced in Dec 2022.
When did TeraImmune last raise funding?
TeraImmune's most recent funding round on record is an undisclosed round of $3.0M, announced in Dec 2022.
Who is the CEO of TeraImmune?
Yong Chan Kim is listed as CEO at TeraImmune.
Where is TeraImmune headquartered?
TeraImmune is based in Gaithersburg, Maryland, United States.
How many employees does TeraImmune have?
TeraImmune is in the 11-50 employee band.
How does TeraImmune's funding compare to other Biotechnology startups?
TeraImmune's latest round of $3.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's TeraImmune Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for TeraImmune is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.